To evaluate the results of laparoscopic Heller myotomy in our group of patients. Method: A retrospective clinical trial was carried out to evaluate the indication, technique and controversies of laparoscopic Heller myotomy in the achalasia treatment. The following symptoms were evaluated prior and after Heller myotomy: dysphagia, heartburn, nausea/vomiting after meal and asthma/coughing. The patients were evaluated by the use of Likert score. Statistical analysis was performed by using Student t test. The intra-operative (operation time, intraoperative complications, blood loss, conversion rate), and peri-operative parameters (morbidity, mortality, hospital stay) were evaluated as well. The patients who underwent laparoscopic Heller myotomy were included in the trial. All patients were perioperatively managed by a multidisciplinary team. Results: The evaluation of fourteen patients was performed (average age: 53.2 yrs., eleven men, two women, BMI 23.6 kg/m 2 ). The patients were indicated for surgery in all of the stages (I-III). Previous semiconservative therapeutic modalities were performed in thirteen patients. The standard laparoscopic technique for Heller myotomy with semifundoplication was applied. All the observed symptoms were statistically improved after the surgery (p=0.05). The average operating time was 89 minutes. Intraoperative blood loss was below 20 ml. There was no conversion to open surgery. An average hospital stay was 4.3 days. Morbidity was 14.3 % and mortality 0 %. In one patient esophageal mucosa perforation was intra-operatively identifi ed and sutured. Post-operative course in this patient was without any complications.
Idiopathic achalasia is a severe neuromuscular disorder of the esophagus. Sir Thomas Willis described this entity in 1674 (1) . Primary idiopathic achalasia is a very rare condition with the incidence of 1:100,000 per year (2) . It is usually diagnosed in patients between 25 and 60 years. The distribution in men and women is proportional. Despite its low incidence this disorder has been very well documented and understood. Its typical features are loss of peristalsis or incoordination of peristalsis in the tubular esophagus. Another feature is the inability of the lower esophageal sphincter (LES) to reach a proper post-deglutitive relaxation. A wide spectrum from absence of optimal relaxation to hypertonus of LES could be identifi ed by manometry (3) . The cause of idiopathic achalasia is a degeneration of nervous cells in plexus myentericus. Especially the cells causing relaxation of LES and distal esophagus are damaged. The etiology of this damage is still elusive (4) . The leading clinical symptom of achalasia is dysphagia. According to literature it occurs in up to 100 % (5). Weight loss, regurgitation, recurrent bronchopulmonal infection, chest pain, hiccups, and cough are other clinical symptoms. Belching refl ex is altered (6) . Incidence of heartburn is 72 %. Although heartburn is a cardinal symptom of gastroesophageal refl ux, the sensation of heartburn in patients with achalasia is explained by the retention of acidic or noxious contents in esophagus or by lactate production from bacterial fermentation within the esophagus (7, 8) . Achalasia is considered as an important precancerosis. The incidence of esophageal cancer is assumed to be between 4-6 % of patients with achalasia (9) . Primary achalasia occurs two hundred times more often in patients with Down syndrome compared with the normal population (10) . The existence of genetic inheritance because of familial cases is suggested (11) . Infection and autoimmune etiology are considered to be other reasons for achalasia (12) Secondary achalasia or pseudoachalasia are caused by narrowing of distal esophagus. The most often case of pseudoachalasia is esophageal and cardia cancers (13) . Another reason is benign strictures. Rare entities such dysphagia lusoria should be mentioned as well. Imaging studies, esophagogastroduodenoscopy, and manometry represent the basic necessary diagnostic tools for the diagnosis and for therapeutic strategy. High-resolution manometry and multichannel intralumi-nal impedance monitoring represent newer techniques. Esophageal endosonography and thoracic/abdominal CT is a routine part of pre-operative diagnostic to exclude secondary achalasia as well.
Method
A retrospective clinical trial was carried out to evaluate the indication, technique and controversies of laparoscopic Heller myotomy in the achalasia treatment. The following symptoms were evaluated prior and after Heller myotomy: dysphagia, heartburn, nausea/vomiting after meals and asthma/coughing. Patients were evaluated using Likert score (0-10 scale). The follow-up data was obtained one year after the surgery. Statistical analysis was performed by using Student t test. Patients who underwent laparoscopic Heller myotomy for achalasia were included in the trial. Esophageal manometry, esophagogastroscopy, esophagogram, and thoracic/abdominal CT were performed before the surgery.
There were no special exclusive criteria in this trial. The intraoperative (time of operation, intraoperative complications, blood loss, conversion rate) and peri-operative parameters (morbidity, mortality, hospital stay) were evaluated as well. The pre-operative diagnostic, management before surgery and peri-operative management were a result of the multidisciplinary team care.
Surgical technique and postoperative management
The standard technique for Heller myotomy was used. Supine position with abducted lower extremities was used. The trocar placement was the same in the antirefl ux surgery. The fi ve-port technique was used. The position of all ports is shown in the scheme (Fig. 1) . One 10-mm, one 12-mm and three 5-mm ports were used. The 10-mm port was placed in the middle line approximately one third above umbilicus in the xiphoideo-umbilical line under direct visualization. A 12-mm port was placed with visual guidance along the left anterior axillary line at the subcostal margin. A 5-mm port was placed contralaterally in the same position. Liver retractor was inserted through this port. One 5-mm port was placed between 10-mm and 12-mm ports. Finally, a 5-mm port was placed in the epigastric area. 12-mm capnoperitoneum was used. The 30-degree optic inserted through the 10-mm port was used. Dissection of pars fl accidum omenti minoris was the fi rst step. The gastrohepatic ligament and the phrenoesophageal membrane were opened by using the hook with diathermy. Both crura were identifi ed and the phrenoesophageal membrane was opened. The exposure of esophagus was achieved. Preparation of fundus with dissection of vasa gastrica brevia followed. We prefer posterior dissection of esophagus not only in patients having non-anatomical position of gastroesophageal junction with hiatal hernia, but in all patients as well. The vagal nerves were identifi ed and preserved. High preparation of thoracic esophagus was performed. The blunt division of the longitudinal muscle fi bers of the esophagus with the dissector was performed. It should be about 1-2 cm above gastroesophageal junction. The dissection with the hook followed after the proper layer had been reached. It was a very important moment. The operation fi eld should be absolutely clear to avoid an injury of esophageal mucosa. Cranial myotomy should be about 6-8 cm long. Myotomy should be caudally extended by 3 cm from the gastroesophageal junction on the ventral wall of the stomach. The complete division of the sling fi bers should be reached. Concomitant esophagogastroscopy was used to guide the myotomy. It helps to avoid an inadequate myotomy and a possible perforation. Perforation is easily identifi able by using endoscopy with an air test. Insuffl ation through the endoscope was performed while the myotomized segment was under irrigant. Semifundoplication according to Dor was a standard part after myotomy in our patients. It helped to secure the myotomised segment and prevented gastro-esophageal refl ux after myotomy. The easy-fl ow drainage was inserted. The ports were removed under a visual control. The wounds were closed. Esophagogram was performed on the fi rst post-operative day. The aim was to evaluate the emptying of esophagus after myotomy and to check its leakage. If the leakage test was negative and the esophagus emptied swiftly, a liquid diet was initiated. The liquid diet followed for the next 4 weeks. The patients were seen in the out-patient-clinic one week after the surgery. Further follow-ups were done in cooperation with a family doctor and a gastroenterologist as well.
Results
We performed an evaluation of fourteen patients with one follow-up (average age: 53.2 yrs., eleven men, two women, BMI 23.6 kg/m 2 ). The indication for surgery was a result of our multidisciplinary team. The patients were indicated for surgery in all of the stages (I-III) (Fig. 2) . Three patients were in stage I, six patients were in stage II, and fi ve patients were in stage III. The duration of symptoms before myotomy was 6.7 years on average. The primary indication for surgery was done only in one patient. In thirteen patients primary pneumatic dilatation and/ or Botox injection was undertaken in parallel to various medicamentous treatments. The standard laparoscopic technique for Heller myotomy with semifundoplication according to Dor was applied. The evaluation of dysphagia by using Likert score prior and after surgery was 8.9±4.1 (mean, SD) and 2.1±1.9 respec- Table 1 . All the observed symptoms were statistically improved after surgery (Student t-test, p=0.05).
The average operating time was 89 minutes. The intraoperative blood loss was below 20 ml. There was no conversion to open surgery. The mean hospital stay was 4.3 days. Morbidity was 28.6 % and mortality 0 %. Esophageal mucosa perforation was intraoperatively identifi ed and sutured in one patient. Post-operative course in this patient was without any other complications. Other complications are summarized in Table 2 .
No patient underwent adjuvant pneumatic dilation or surgery within the one-year follow-up. Thirteen (92.8 %) patients reported their satisfaction with the procedure.
Discussion
The main problem in achalasia treatment is that the etiology of achalasia remains still unknown. The restoration of esophageal peristalsis and lower esophageal sphincter relaxation in physiological sense is not available at the present time. This is the reason why the treatment is not causal and remains in palliative range. There are some possibilities of pharmacological treatment, chemical denervation, pneumatic dilatation, or surgical myotomy. The aim of palliative therapy is to open or to destroy lower esophageal sphincter to facilitate the esophageal transit. A radical option for terminal stage with irreversible progression is esophagectomy. Techniques for the treatment of megaesophagus in patients who underwent myotomy like cardiaplasty and Roux-en-Y partial gastrectomy (Serra-Dória procedure) have been described.
The primary diagnostic procedures are performed usually by nonsurgeons. Myotomy is considered to be an invasive procedure. It is the reason why many patients go to surgery secondarily after a conservative and repeatedly unsuccessful semiconservative treatment. In our cohort the majority of patients (92.8 %) indicated for myotomy after the previous semiconservative therapy. Achalasia is diagnosed on average fi ve years after the onset of the fi rst diagnosed symptoms. In our cohort it was 6.7 years. It represents a second problem, because the treatment starts in the advanced and more complicated stages of disease (14) . Considering the above mentioned fact of the late indication for surgery after semiconservative treatment and the late diagnosis the patients go to surgery with a signifi cant delay. Achalasia is a rare illness. Only few randomized controlled clinical trials have been performed with the aim to show the best treatment strategy. Cardiomyotomy was originally described by Ernst Heller in 1913. He originally used anterior and posterior myotomies (15) . The Dutch surgeon Zaaijer described an anterior cardiomyotomy with the aim to decrease the excessive gastroesophageal refl ux after anterior and posterior myotomies (16) . In the nineties minimal invasive surgery brought other possibilities with laparoscopic approach or video-assisted thoracoscopic surgery. The thoracoscopic approach is applied in case of the simultaneous presence of an epiphrenic diverticulum, or concurrent diffuse esophageal spasm in order to perform a long thoracic myotomy (17) .
Until the nineties of the 20th century endoscopic dilatation was considered to be a fi rst-line therapy (18) .
It was confi rmed, that recurrence after pneumatic dilatation was experienced by approximately 40 % of patients (19, 20) . Zaninotto compared patients treated with Botox injections and with laparoscopic Heller myotomy and fundoplication. 66 % of the patients in Botox group had recurrence. In the laparoscopic Heller myotomy group the recurrence was 13.5 % (21).
Thanks to the minimal invasive myotomy this technique became a fi rst line therapy. Endoscopic methods should be reserved for patients who are poor surgical candidates (22) .
The debate about the appropriate initial management continues despite the superior data of surgical approach. The discussion about the possible negative infl uence of the previous semiconservative treatment on the outcome of the surgical therapy goes on. Some authors emphasize the fact that patients initially treated preoperatively with Botox injection had a more diffi cult laparo- scopic Heller myotomy. A correlation between the diffi culty and preoperative pneumatic dilatation was not confi rmed in this trial (23) . Cowgill confi rmed no correlation between degrees of fi brosis in the esophageal muscle with preoperative endoscopic therapy and concluded that the preoperative endoscopic therapy before laparoscopic Heller myotomy did not determine the diffi culty of the operation or long-term outcomes (24) . There are more trials with different results. Many questions have arisen regarding the outcomes after laparoscopic Heller myotomy. The following should be taken into consideration: the frequency and severity of gastroesophageal refl ux, the need for an antirefl ux fundoplication, the need for intraoperative endoscopy, the extent of myotomy, the need for robotics, and others.
The procedure facilitating transit without pathological gastroesophageal refl ux is optimal. Most authors recommend to combine the myotomy with fundoplication. Myotomy without antirefl ux procedure is rare. The advantages of partial or complete fundoplication were debated as well. Gockel suggested that complete fundoplication is rare because of the risk of persistent postoperative hypertension of the sphincter. 180 o anterior Dor semifundoplication might be important because of covering the occult mucosal perforation. The dorsal 270 o fundoplication could keep apart the edges of muscles after myotomy (25) . The fundoplication should not be too tight. Di Martino compared Dor laparoscopic semifundoplication and calibrated Nissen-Rossetti fundoplication with the achieved similar results (26) . The anterior semifundoplication was recommended according to Richard trial (27) . The patients in our cohort received Dor semifundoplication.
The length of cranial myotomy should be 6-7 cm and caudally 1.5-2 cm. The incomplete division of muscle fi bers is another reason for recurrence (28) . Craft recommended the length of myotomy approximately 10 cm up the esophagus and 4cm down in the anterior gastric wall (29) . Wright confi rmed the effi cacy of myotomy above 3 cm on to the stomach in terms of reducing persistent dysphagia (30) . The direction of the myotomy over the stomach is debated as well. Scar formation, short myotomy or remnant muscle fi bers are the most cited causes of recurrence after myotomy. Gockel mentioned the possibility of addition posterior myotomy to the scheduled anterior myotomy.
The complication rate after pneumatic dilatation and surgical myotomy is very important. Many reviews show the incidence of mucosa lesion about 4 %. The lethality after myotomy is about 0.5 % (31). The perforation rate after pneumatic dilation is about 1 % per dilation session and lethality below 0.5 % (32). The results of meta-analysis would suggest that pneumatic dilation is the more effective endoscopic treatment in the long term (greater than six months) for patients with achalasia (33) .
Gockel presented an interesting trial regarding persistent and recurrent achalasia after Heller myotomy. She identifi ed two groups of patients with therapeutic failure. The fi rst group had an early recurrence after technical failure of myotomy or a scarring process. It is important to follow the standardized operation technique to avoid this type of recurrence. The second group had a late recurrence with irreversible progression of the disease. These patients developed megaesophagus. An analysis of potential predictors for the operation results would be interesting. A bigger cohort of patients would enable such analysis.
New techniques are being developed. The recent experimental studies in mice suggest that transplantation of neuronal stem cells might be a future therapeutic option. Neuronal stem cells injected in the pylorus survived and even expressed nitric oxide synthase (34) . Pasricha reported a method of submucosal endoscopic myotomy with no skin incision in an experimental model (35) . The long-term results of techniques like oral endoscopic myotomy have not been available. A similar situation exists in the stent introduction in achalasia treatment.
Thanks to the genes diagnostics it will be possible to early identify some cases with achalasia in the future. They are several risky genes for achalasia. The Achalasia Risk Consortium has been founded to help to identify these risky genes and to make the gene therapy possible in the future (www.achalasie-konsortium.de) (36) .
Conclusion
The precise history helps to identify the disease in its early stage. The correct and early indication for surgery is crucial. Laparoscopic Heller myotomy has been established as a fi rst-line therapy for severe achalasia including old fi t patients. An operation with this approach is safe, effi cient, and with excellent reproducible operative results. Patient´s preference should be included in the decision-making process. It can be considered as a secondary treatment if the patient does not respond to less invasive modalities. In the future other techniques could be developed. Further studies are needed to investigate the role of immunosuppressive therapies when an autoimmune etiology is suspected.
